Join our community of smart investors

Reckitt Benckiser recovery under way

The health and hygiene group will benefit from its 2017 acquisition of Mead Johnson Nutrition
February 19, 2019

At the half-year mark, a better-than-expected performance from Reckitt Benckiser's (RB.) infant formula and child nutrition (IFCN) division prompted an increase in expectations for constant currency net revenue growth of between 14 and 15 per cent. Ultimately, the group achieved the top end of the revised range for 2018, aided by a full-year contribution from Mead Johnson Nutrition (MJN), while $211m (£163m) of related cost synergies were also delivered, well on the way to the $300m target. 

IC TIP: Buy at 6294p

The acquisition was undertaken to drive Reckitt's transformation from a consumer goods group to a health and hygiene business, but self-help measures are also enhancing performance. Chicago-based MJN has been on the books for only 18 months, but has returned to growth following two years of net revenue declines.

Top-line growth for the group was more prosaic on a pro-forma/like-for-like basis, although a 3 per cent increase still represents a creditable outcome and is in line with the 2019 target rate. The growth rate accelerated through the final quarter, moving 0.7 per cent ahead of consensus, aided by a strengthening performance at the hygiene home division in North America. This is set against a 40 basis point reduction in the gross margin to 60.6 per cent as the group struggled to contain input costs, together with a difficult pricing environment in the hygiene business.

Analysts at UBS expect EPS of 348p in 2019, increasing to 379p in 2020.

RECKITT BENCKISER (RB.)  
ORD PRICE:6,294pMARKET VALUE:£44.5bn
TOUCH:6,292-6,295p12-MONTH HIGH:7,174pLOW: 5,255p
DIVIDEND YIELD:1.7%PE RATIO:21
NET ASSET VALUE:2,084p*NET DEBT:70%
Year to 31 DecTurnover (£bn)Pre-tax profit (£bn)Earnings per share (p)Dividend per share (p)
20148.82.13231139
20158.92.21244139
20169.52.25246153
201711.42.50481164
201812.62.72307171
% change+10+9-36-34
Ex-div:18 Apr   
Payment:23 May   
*Includes intangible assets of £30.3bn, or 4,280p a share